Standard BioTools CEO has shares withheld for taxes
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
STANDARD BIOTOOLS INC. President & CEO Michael Egholm reported a tax-withholding disposition of 362,625 shares of common stock on August 3, 2026 at $0.868 per share. The shares were withheld to satisfy tax obligations triggered by vesting restricted stock units granted on August 1, 2025. After this transaction, Egholm directly owns 6,235,331 common shares.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Tax Withholding | Common Stock F1 | 362,625 | $0.868 | $315K |
Footnotes (1)
- F1. The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of restricted stock units granted to the reporting person on August 1, 2025, which grant was originally reported on a Form 4 filed with the U.S. Securities and Exchange Commission on August 5, 2025.
Key Figures
Key Terms
restricted stock units financial
tax withholding obligations financial
U.S. Securities and Exchange Commission regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did STANDARD BIOTOOLS (LAB) CEO Michael Egholm report?
Was the LAB Form 4 transaction reported under a Rule 10b5-1 trading plan?
What triggered the tax-withholding disposition reported for STANDARD BIOTOOLS (LAB)?
AI-generated analysis. How Rhea-AI works. Not financial advice.